start difficult
core growth opm ep ahead est
sale yoy fx vs our/street est
core growth vs estimate vs gm adj
opm flat yoy yoy respect strong oper
effici off-set tariff fx non-gaap ep y/i vs
street overal agil solid start year toughest comp
soft perform quarter lsag core face head-
wind tough comp core growth well us government shutdown
januari trade/tariff china management think lull temporari agil
highlight two new gc system updat flagship may
contribut lsag soft custom delay purchas
new system avail elsewher portfolio outperform core
growth dgg core acg end-market also robust core
growth pharma broad-bas strength envt forens
dx clinic tough comp neg affect result segment
expect chemic comp flat
instrument solid result recur revenu government flat
comp food china regulatori issu anniversari next qtr
growth america hsd lsd europ china ex-food regulatori china
msd comp much easier comp
updat guid prudent still conserv
overal given tough comp transient headwind china food agenc us
government shutdown fact management alreadi building-in tariff china
full year see updat guid still organ sale growth
adj ep like conserv reiter
buy rate given solid end market strong portfolio improv execut
rais est see sale adj ep po
rais base ebitda estim vs prior
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
headquart santa clara california agil
technolog lead supplier analyt
instrument consum product
use mainli research qualiti assur
applic custom life scienc
chemic analysi industri compani
known leader life scienc
industri long histori innov
well posit benefit
secular posit growth trend life
scienc chemic analysi food
environment test acquisit also
provid new opportun growth
under-penetrated market agil reduc
cyclic exposur restructur
spin electron test measur
busi keysight help unlock sharehold
valu increas strateg flexibl
po base ev/ebitda multipl modest premium
median valuat agil life scienc peer group believ justifi
given agil margin expans potenti upsid new gc product cycl
opportun capit deploy execut
risk po econom risk fx risk slower expect uptak new
product expans new market competit risk reduct spend
integr risk takeout specul overhang
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
